NEWS
 
Except for the legal person of ICG's investment subject, no other individual or institution has the right to sign the investment agreement with the project party on behalf of ICG. ICG does not charge any fees other than investment returns and management fees during the investment process.
ICG contributes to the healthy China strategy by investing in the health industry

On April 27, 2022, The State Council issued the 14th Five-year National Health Plan, calling for comprehensively promoting the construction of a Healthy China and accelerating the implementation of the Healthy China Action plan. Driven by multiple positive factors, such as national policy guidance, demand from an aging population and consumption stimulated by the promotion of national health awareness, the big health industry is rising rapidly. The explosive growth of market scale makes relevant industrial enterprises urgently need to provide strong support with high-quality capital, which is also the responsibility and mission of current financial investment institutions.


As a state-owned joint-stock investment group, ICG is committed to serving major national strategies such as "The Belt and Road Initiative" and "Healthy China 2030", acting as a financial pioneer and actively serving the real economy. The group helps enterprises through creditor's rights investment and equity investment to stimulate the vitality and creativity of market players, thus enhancing the resilience and potential of China's economic development. According to authoritative statistics, ICG invested a total of 199.86 billion yuan in each business sector in 2021, involving a total of 209 investment projects, demonstrating its original intention to serve the real economy and its determination to develop with high quality.


In order to actively respond to the "Healthy China 2030" strategic deployment, ICG, relying on professional investment experience and smooth financial channels, is constantly exploring and expanding the equity investment model for the big health industry, promoting the development of high-quality enterprises with high growth through industrial investment and securities investment, and meeting the equity financing needs of enterprises at all stages of development. Promote the healthy China strategy through financial power.


In the field of industrial investment, ICG focuses on promoting the scale and performance improvement of the big health industry, optimizing asset allocation, helping enterprises connect with the trading markets of China, Hong Kong and the United States, and actively grasping the development dividend of the domestic securities market and the opportunity of connecting with the international capital market. At the same time, the financial services ICG precision cover large health enterprise each stage of development, through the angel investment, venture capital (VC), private equity (PE), pre - IPO&IPO, mergers and acquisitions, private placement, international investment placement, and other forms of investment to provide high quality enterprise capital can assign and resources assigned to, build a "whole" stage financing system. For the development of big health industry cluster, ICG will integrate manufacturing, service and consumption to form the value circulation of the whole industry chain, and then promote the sustainable, high-level and high-quality development of big health industry cluster.


In the field of securities investment, ICG relies on the data and results of macroeconomic research, special market research, investment decision execution and other related professional research, arranges multi-category and multi-level financial investment such as stocks, bonds, funds and financial derivatives of the big health industry, actively optimizes the industrial structure and effectively improves the liquidity of industrial capital. In the long term, the big health industry has strong development potential. Strong policy certainty, continuous progress of technology and wide application prospects also make ICG full of confidence in the big health track.


At present, the big health industry has formed a new economic growth point. According to the Outline of Healthy China 2030 Plan, the market size of China's big health industry is expected to reach 16 trillion yuan by 2030, and it is expected to become one of the pillar industries of China's economy. With great health industry as a whole market active, many large investment institutions including ICG will get more investment opportunities, promote the health industry accelerates towards a more comprehensive, more efficient, more mature and new stage, in order to realize the co-construction and sharing, the national health "promoting the construction of" healthy China "strategic target, make greater contribution.